Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Yuichi Iwaki
Person

Yuichi Iwaki

Tracked across 1 events · 7 articles · First seen Jan 29, 2026 · Last active Jan 29, 2026

Sentiment
60
Attention
4
Events
1
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 60
Business
MediciNova's MN-166 ALS Study Reaches 50% Enrollment
As President and CEO of MediciNova, Yuichi Iwaki commented on the substantial progress of the SEANOBI program, highlighting the importance of patient participation and the support from the United States===National Institute of Neurological Disorders and Stroke (NINDS) for advancing Ibudilast towards approval.
Jan 29, 2026 · 7 articles
Relationships (2)
United States===National Institute of Neurological Disorders and Stroke ↔ Yuichi Iwaki Unknown
MediciNova CEO of ↔ Yuichi Iwaki Yuichi Iwaki is the President and CEO of MediciNova, leading its strategic direc
NEWSDESK
Track Yuichi Iwaki live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.